Abstract
Background and Aims : Residual inflammatory risk is identified by hsCRP level ≥2.0 mg/l. Monomeric CRP (mCRP) is an emerging inflammatory biomarker. We studied whether mCRP level is a better predictor of carotid atherosclerosis (CA) progression than hsCRP in patients with low-grade CA and moderate SCORE risk which achieved target LDL cholesterol (LDL-C) level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
